Drugs / Kunxian capsule
Kunxian capsule
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00953979 Comparator | Jan 2008 → Sep 2009 | ankylosing spondylitis | Gu Jieruo | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kunxian capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00953979 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Kunxian capsule, a Chinese patent medicine which has been used in the treatment of immunologic diseases for many years in China, has anti-inflammatory and immunoregulatory effects.” PMID 27449221 ↗ Jul 2016 |
| Route | Oral | “Patients should take 2 tablets per time and 3 times per day for 12 weeks.” NCT00953979 ↗ |